Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Bristol/Myers Squibb Co
Recent news which mentions Bristol/Myers Squibb Co
< Previous
1
2
Next >
What's next for the Biden administration's Medicare drug price negotiations
August 15, 2024
Tags
Politics
Bristol/Myers Squibb Co
Merck & Co Inc
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Amgen Inc
Merck & Co Inc
Bristol/Myers Squibb Co
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Abbvie Inc
Healthy Returns
Breaking News: Politics
From
CNBC.com News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
July 26, 2024
Tags
Breaking news
Business
Pharmaceuticals
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Johnson & Johnson
Health care industry
Novartis AG
From
CNBC.com News
5 things to know before the stock market opens Monday
July 22, 2024
Tags
Delta Air Lines Inc
Voting
5 Things to Know
From
CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
Tags
COVID/19
Business News
Health & Science
From
CNBC.com News
Cramer's Lightning Round: 'I would not abandon' Cava
June 24, 2024
Tags
Market Outlook
Stock Picks
CAVA Group Inc
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
AstraZeneca PLC
Moderna Inc
Health & Science
From
CNBC.com News
Cramer's Lightning Round: Apple is a buy
May 28, 2024
Tags
Apple Inc
S&P 500
T Rowe Price Group Inc
From
CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Pharmaceuticals
Breaking News: Investing
Health & Science
From
CNBC.com News
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
April 29, 2024
Tags
Health care industry
Johnson & Johnson
Biotech and Pharmaceuticals
From
CNBC.com News
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
April 25, 2024
Tags
Bristol/Myers Squibb Co
Biotech and Pharmaceuticals
Pfizer Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Ford Motor Co
Investing
Biogen Inc
From
CNBC.com News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
April 09, 2024
Tags
Health & Science
Bristol/Myers Squibb Co
Biotech and Pharmaceuticals
From
CNBC.com News
Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
March 01, 2024
Tags
Health care industry
Biotech and Pharmaceuticals
Bristol/Myers Squibb Co
From
CNBC.com News
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
February 13, 2024
Tags
Law and Regulation
US: News
Companies
From
CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
February 08, 2024
Tags
Congress
Health care industry
Johnson & Johnson
From
CNBC.com News
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
February 02, 2024
Tags
Energy
Bristol/Myers Squibb Co
Merck & Co Inc
From
CNBC.com News
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
February 02, 2024
Tags
Pfizer Inc
Biotech and Pharmaceuticals
Bristol/Myers Squibb Co
From
CNBC.com News
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
January 30, 2024
Tags
Health care industry
Johnson & Johnson
Healthy Returns
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Apple Inc
Merck & Co Inc
Pfizer Inc
From
CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
Tags
Alvotech SA
Johnson & Johnson
Karuna Therapeutics Inc
From
CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company'
January 08, 2024
Tags
Stock Picks
Investment strategy
Markets
From
CNBC.com News
Cramer cheers Monday's tech gains, but tells investors to keep a diverse portfolio with an eye towards health care
January 08, 2024
Tags
Investment strategy
Stock Picks
Amazon/com Inc
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
Investing
Business News
Amgen Inc
From
CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
January 05, 2024
Tags
Business News
Investing
Wells Fargo & Co
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
Bristol/Myers Squibb Co
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
December 22, 2023
Tags
Science
Health care industry
Karuna Therapeutics Inc
From
CNBC.com News
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.